Regeneron Reports Fourth Quarter and Full Year 2017 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
Regeneron (REGN) Tops Q4 EPS by 70c
February 8, 2018 6:32 AM ESTRegeneron (NASDAQ: REGN) reported Q4 EPS of $5.23, $0.70 better than the analyst estimate of $4.53. Revenue for the quarter came in at $1.58 billion versus the consensus estimate of $1.5 billion.
Fourth quarter 2017 EYLEA® (aflibercept) Injection U.S. net sales increased 14% to $975 million versus fourth... More